Group 2 innate lymphoid cells program pulmonary adaptive immunity via granulocyte-macrophage colony-stimulating...

Area of Science:

• Immunology
• Respiratory Medicine
• Allergy and Asthma Research

Background:

• Group 2 innate lymphoid cells (ILC2s) and CD4+ T_H2 cells are central to type 2 immunity and asthma pathology.
• ILC2s produce innate cytokines, while T_H2 cells provide adaptive memory, but their interaction is poorly understood.

Purpose of the Study:

• To investigate the role of ILC2s in establishing adaptive antigen-specific immunity in a mouse model of asthma.
• To elucidate the mechanisms by which ILC2s influence adaptive type 2 immune responses in the lungs.

Main Methods:

• Utilized ILC2-deficient mice intranasally sensitized to ovalbumin (OVA) with Alternaria extract.
• Assessed immune responses via flow cytometry and OVA recall challenge.
• Employed gene-deficient mice, antibody neutralization, adoptive transfer, and in vitro cultures to investigate mechanisms.

Main Results:

• Alternaria exposure increased lung dendritic cells (DCs) and T_H2-recruiting chemokines, suppressed in ILC2-deficient mice.
• ILC2 deficiency impaired T_H2 cell memory development and antigen-induced airway inflammation.
• Adoptive transfer of ILC2s restored these responses; granulocyte-macrophage colony-stimulating factor (GM-CSF) from ILC2s was essential.

Conclusions:

• ILC2s license lung DCs via GM-CSF to prime and recruit T_H2 cells.
• This licensing establishes antigen-specific T-cell immune memory in the lungs.
• ILC2s bridge innate and adaptive immunity, crucial for allergic airway responses.